Slide Insurance Holdings, Inc.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On June 18, 2025, we completed the initial public offering of our common stock pursuant to the Registration Statement which was declared effective by the SEC on June 17, 2025. Pursuant to the Registration Statement, we registered, issued and sold an aggregate of 24.0 million shares of our common stock, of which 16.7 million shares were sold by us and 7.3 million shares were sold by certain selling stockholders named therein at a price to the public of $17.00 per share (for an aggregate offering price of $408.0 million). The Company received net proceeds of approximately $263.5 million, net of approximately $19.8 million of underwriting discounts and commissions. On June 25, 2025, the underwriters fully exercised their option to purchase an additional 3.6 million shares of common stock from certain selling stockholders of the Company at a price of $17.00 per share bringing the aggregate offering price to $469.2 million. The Company did not receive any proceeds from the sale of shares of common stock by selling stockholders. In connection with the IPO, we effectuated an approximately 5.5-for-one stock split of its common stock, preferred stock, vested and unvested stock options and vested and unvested restricted share units. Barclays Capital Inc. and Morgan Stanley & Co. LLC acted as joint book-running managers.

We did not make any payments of expenses in connection with the offering to directors, officers or persons owning ten percent or more of any class of our equity securities, or to their associates, or to our affiliates.

There has been no material change in the planned use of proceeds from our IPO as described in the related prospectus filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended.